Form 4 for TXG 10x Genomics, Inc.

Accepted 2021-10-20 00:00:00 ET · period of report 2021-10-18 · accession 0001567619-21-018503 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2021-10-20	2021-10-18	TXG	STUELPNAGEL JOHN R	Dir	S - Sale	$150.67	-5,000	361.9K	-1%	-$753.3K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Class A Common Stock	2021-10-18	S	D	4,400	$150.51	362,216	D	—	—	(F2) This transaction was executed in multiple trades at prices ranging from $150.00 to $150.96. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
2	Common	Class A Common Stock	2021-10-18	S	D	300	$152.20	361,616	D	—	—	(F4) This transaction was executed in multiple trades at prices ranging from $151.79 to $152.60. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
3	Common	Class A Common Stock	2021-10-18	S	D	300	$151.41	361,916	D	—	—	(F3) This transaction was executed in multiple trades at prices ranging from $151.03 to $151.68. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.